Mission Creek Capital Partners, Inc. Pfizer Inc Transaction History

Mission Creek Capital Partners, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $258,822 - $297,210	9,997 New	9,997 $277,000
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $1,102 - $1,435	28 Added 0.47%	6,013 $245,000
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $6,554 - $8,556	-157 Reduced 2.56%	5,985 $306,000
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $50,874 - $63,039	-1,112 Reduced 15.33%	6,142 $318,000
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $26,537 - $30,062	-739 Reduced 9.25%	7,254 $284,000
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $3,784 - $4,268	-113 Reduced 1.39%	7,993 $290,000
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $4,351 - $5,532	130 Added 1.63%	8,106 $298,000
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $5,238 - $6,146	-165 Reduced 2.03%	7,976 $293,000
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $451 - $548	15 Added 0.18%	8,141 $266,000
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $267,507 - $303,587	8,126 New	8,126 $318,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Mission Creek Capital Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Mission Creek Capital Partners, Inc. with notifications on news.